Klacid Pediátrico

Clarithromycin, the active ingredient in Klacid Pediátrico, is a macrolide antibiotic presented as an oral pediatric formulation for oral use. It treats bacterial infections such as pneumonia, sinusitis and skin infections in children and young adults and is widely used in pediatric care.

GNH USA supplies Klacid Pediátrico as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance in all shipments.

Clarithromycin is indicated for bacterial infections affecting the respiratory tract and skin, where it targets susceptible organisms. - Community‑acquired pneumonia: Reduces bacterial load and improves clinical recovery in pediatric patients. - Acute bacterial sinusitis: Alleviates sinus inflammation by eradicating the causative bacteria. - Skin and soft tissue infections: Controls infection and promotes healing of cellulitis, impetigo and related conditions.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild stomach upset. - Diarrhea: loose stools. - Taste disturbance: temporary alteration of taste. - Headache: mild to moderate headache.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice. - QT prolongation: cardiac rhythm changes that may lead to arrhythmia. - Severe allergic reactions: rash, swelling, or anaphylaxis.

When prescribing Clarithromycin for pediatric patients, several precautions should be observed to ensure safety and effectiveness. - Assess liver function: evaluate hepatic status before initiating therapy. - Monitor cardiac risk: avoid use in patients with known QT prolongation or electrolyte imbalance. - Review drug history: check for concomitant use of strong CYP3A4 inhibitors. - Adjust for renal impairment: consider dose modification in severe renal dysfunction. - Counsel on adherence: ensure full course is completed to prevent resistance. - Store below 25°C: keep in the original pack, protect from moisture.

Clarithromycin interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may cause toxic plasma levels. - Certain antiarrhythmics (e.g., amiodarone, sotalol): increase risk of QT prolongation. - Statins metabolized by CYP3A4 (e.g., simvastatin, lovastatin): heightened risk of myopathy.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Theophylline: possible increase in serum concentrations. - Oral contraceptives: may reduce efficacy, advise alternative contraception.